MedChemExpress
medchemexpress.bsky.social
MedChemExpress
@medchemexpress.bsky.social
15 followers 20 following 130 posts
MedChemExpress (MCE) | US Headquartered 🌎 Global Warehousing Inhibitors & Agonists | Proteins | Drug Screening Platform
Posts Media Videos Starter Packs
🎃Spooky Fun with #MedChemExpress!
👻Happy #Halloween! Cece is all dressed up, and our lab is buzzing with tricks, candies, and a dash of science magic! Tell us — what’s your favorite Halloween lab snack? 🍬

#LabLife #HalloweenVibes #ScienceFun #TrickOrTreat #SpookyScience #HalloweenMood #LabHalloween
🤝MedChemExpress on the Move in the US | #ADDC 2025
🎈We sincerely thank everyone for the enthusiastic conversations at our poster and booth. We are excited to continue supporting your work with high-quality products and services in drug discovery. 👉 ow.ly/HW5W50Xk7m0
🔥Hot Off the Press | Nature (2025): New insights into PDAC heterogeneity and signaling
🔹Epithelial ↔ Mesenchymal cell interplay
🔹Drives diversity & drug resistance
🔹Targeting these transitions = new therapy avenue
#PancreaticCancer #CancerTherapy #Oncology
📰New & Featured | New in #Cell: The #fetal #immune system is systemically active and self-regulating.
He et al. reveals cross-organ T cell memory, #ARG1⁺ neutrophil–mediated tolerance, and widespread #hematopoiesis across fetal organs.
#Immunology #DevelopmentalBiology #TCells
🤝MedChemExpress on the Move in US | #Pennington Biomedical Research Center at #LSU-Baton Rouge
👻It was a treat having you visit our #Halloween-themed booth! 🎃 We’re proud to stand behind your experiments and discoveries. 🔬💡
📰New & Featured | 🧠 New #Cell study: Cancer hijacks pain-sensing neurons to suppress #immunity.
Through the #ATF4-SLIT2-CGRP pathway, tumors reprogram lymph nodes into an immune-suppressed state.
Blocking this loop or using migraine drug rimegepant can restore #anti-tumor immunity.
#CancerResearch
💊#FDA Approval Update | #Lynkuet® (#elinzanetant) is now approved for moderate to severe menopausal hot flashes — the first dual #NK1,3 receptor antagonist.
⚙️By blocking NK1,3 signaling on #KNDy neurons, it helps regulate thermoregulation and reduce hot flashes.
✔️Backed by Phase III OASIS trials
📰New & Featured | 🧬New study in Cell Metabolism reveals that Hormone-Sensitive Lipase (#HSL) isn’t just a fat-burning enzyme — it also acts inside the nucleus of fat cells to regulate gene expression and maintain #adipose tissue. This dual role reshapes our understanding of #fat #metabolism.
💡 Join Our Upcoming Webinar | #Antimalarial
📅 Wed, Oct 29, 2025 (Online via Zoom)
🎙️ Brad Sleebs, PhD — Laboratory Head, Walter & Eliza Hall Institute
🔗 www.medchemexpress.com/webinar-Brad...
🦠 #Malaria remains a global challenge, intensified by drug resistance.
🔥Hot Off the Press | Nature: A PSMA-targeted #Nano-PROTAC using self-assembling nanotech can simultaneously degrade AR & HSP90, suppressing castration-resistant prostate cancer (#CRPC) and prolonging survival. MedChemExpress offers biological and chemical products to generate diverse disease models.
👑 The crown jewel of antifungal research has everyone talking. At the #museum of #biochemistry, all eyes are on the crown jewel of antifungal research: #Fluconazole (HY-B0101). A powerful #antifungal featured in 17 research publications.
🔗 www.medchemexpress.com/Fluconazole....
🔥Hot Off the Press | New in Science Advances: Early #VCAM-1 expression in kidney tubules flags nephrons headed for loss. It marks failed repair, recruits #PDGFRβ⁺ cells & precedes fibrosis + #CKD.
👉 A potential early biomarker & target to stop #AKI → CKD transition.
🚀From Bench to Paper | Research in Signal Transduction and Targeted Therapy highlights a promising #Nano-PROTAC for castration-resistant prostate cancer (#CRPC). This PSMA-targeted agent degrades #AR, its chaperone #HSP90, and resistant #AR-V7 (a splice variant).
A new way to beat CRPC resistance.
📰New & Featured | Science Signaling: Cxcl12 and Shh/Ihh act as injury-induced niche factors that coordinate suture stem cell activation and bone regeneration.
➡️ Cxcl12-Cxcr4 signaling guides Gli1⁺ stem cell migration
➡️ Shh/Ihh promote osteogenic differentiation
#CranialRepair #Osteogenesis
✨More from “Magic Cece’s Island Day” Blind Box!
Cece’s found the perfect lookout spot! 🌺🌴
The Explorer & Coconut Cabin come together for double the fun (and coconuts 🥥).
#MedChemExpress #BlindBox #MiniatureWorld #MiniatureArt #BeachVibes #MiniScene #Lab #CollectibleToys
“Magic Cece’s Island Day” #BlindBox is Here!
Music, pastries, and a beachside bonfire.
🎸+🍞 = the sweetest duet
Cece’s Guitar Poet and Bakery Van can be assembled into one perfect beach night.
Collect them both and complete the scene
#MiniatureWorld #MiniatureArt #MiniScene #LabMerch #CollectibleToys
✨ “Magic Cece’s Island Day” Blind Box
Meet Dali’s Sunset 🌅💜 Chasing sunsets and dreams
#MedChemExpress #BlindBox #MiniatureWorld #MiniatureArt #BeachVibes #MiniScene #Lab #CollectibleToys
🔥Hot Off the Press | #Tumor #CRATERs: Hotspots of #CD8⁺ T Cell Power
🐟Using a #zebrafish #melanoma model, researchers captured CD8⁺ T cells forming “CRATERs” — #Cancer Regions of Antigen presentation & T cell Engagement and Retention.
🔗 ow.ly/m3At50XgGwE
#Tcells #CancerResearch #CheckpointBlockade
📚MedChemExpress Digest | Targeting #Lipid #Metabolism in #Cancer
🔬Cancer cells reprogram lipid uptake, synthesis & oxidation to fuel growth, survive stress & evade immunity. These pathways (#CD36, #FASN, #ACLY, #ACC, #SREBP) offers promising anticancer strategies. 👉Discover more: ow.ly/8RmS50XgbgE
🚀From Bench to Paper | 🧬Science: #MTAP-deficient tumors resist STING agonists by silencing #IRF3 signaling—but this can be reversed via polyamine metabolism targeting.
#E7766, a synthetic cyclic dinucleotide #STING agonist, helped reveal this mechanism.
🌟Get E7766 at MedChemExpress.
👨🔬👩🔬 We're thrilled to announce that #MedChemExpress will be exhibiting at the #AACR-NCI-EORTC International Conference on Molecular Targets and #Cancer Therapeutics.
📆 October 22–26, 2025
📍 Hynes Convention Center, Boston, MA.
🔽 For More Information:
lnkd.in/gEWR25pd
#ADC #TargetedTherapies
🧬 Molecule of the Moment: #mRNA4359 + #pembrolizumab
At #ESMO2025, #Moderna reported early Phase 1/2 data showing mRNA-4359 may overcome checkpoint inhibitor–resistant #melanoma by targeting #PDL1 & #IDO1 pathways. Combo with pembrolizumab showed manageable safety, no new immune AEs.
📰New & Featured | Cell: #Anti-BCMA #CAR-T therapy tested in 5 patients with progressive #MS.
🧬 Depletes #CNS plasma cells
🧩 Reduces microglial activation
✅ Improved disability scores
🔗Read more: www.cell.com/cell/fulltex...
#Immunotherapy #CART
📰New & Featured | #Nature: #RNA profiling reveals molecular clues behind cancer-associated cachexia 🧬
➡️ Distinct expression patterns in skeletal muscle
➡️ New targets for reversing cancer-related muscle loss
🔗Read more: www.nature.com/articles/d41...
#Cachexia #MuscleLoss #Cancer #SkeletalMuscle